| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $3.05B | +0.9% |
| Cost of Revenue | $1.93B | +3.8% |
| Gross Profit | $1.12B | -3.6% |
| R&D Expense | $34.7M | +0.6% |
| SG&A Expense | $484.5M | -0.6% |
| Interest Expense | $158.4M | -2.1% |
| Pre-tax Income | -$305.5M | -298.1% |
| Income Tax | -$74.0M | -1004.5% |
| Net Income | -$231.5M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $205.3M | -14.1% |
| Accounts Receivable | $421.7M | +44.0% |
| Inventory | $771.6M | +5.9% |
| Current Assets | $1.59B | +10.5% |
| Total Assets | $4.57B | -8.7% |
| Current Liabilities | $697.9M | -26.3% |
| Long-term Debt | $3.55B | +4.7% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.0M | -99.4% |
| Capital Expenditures | $77.8M | +19.9% |
| Investing Cash Flow | -$90.9M | +28.1% |
| Financing Cash Flow | $79.1M | +107.4% |
| Free Cash Flow | -$76.8M | -166.9% |
| -243.9% |
| EPS (Basic) | -$3.37 | -259.0% |
| EPS (Diluted) | -$3.37 | -259.7% |
| Total Liabilities |
| $4.44B |
| -4.5% |
| Stockholders' Equity | $130.6M | -63.3% |